Signal detection in OnePV
One pair stands out
Pharmacovigilance signal detection and management in OnePV: PRR, ROR and EBGM across your data plus FAERS, EVDAS and VAERS, with a recorded decision for every signal.
Signal detection can also run alongside Oracle Argus or ArisGlobal while you plan a move.
A sample signal drawn as a two-by-two table of reports. Exampril with anaphylactic reaction: 12 reports, 2.9 expected. Exampril with all other events: 488. All other products with anaphylactic reaction: 1,450. All other products with all other events: 248,550. Each column stands as tall as its observed-to-expected ratio: the Exampril and anaphylactic reaction column stands at about 4.1, rising through a threshold plane at 2; the other three stand at about 1. PRR 4.1, above the threshold.
Three methods, one pair
The same four counts, worked three ways.
| Anaphylactic reaction | All other events | |
|---|---|---|
| Exampril | a12 | b488 |
| All other products | c1,450 | d248,550 |
a + b = 500c + d = 250,000a + c = 1,462N = 250,500
- PRRProportional reporting ratio
- 4.1
- a divided by a + b÷c divided by c + d=12 divided by 500÷1,450 divided by 250,000
- χ² 25.4 · n 12 · 95% CI 2.4 to 7.3
- RORReporting odds ratio
- 4.2
- a × d divided by b × c=12 × 248,550 divided by 488 × 1,450
- 95% CI 2.4 to 7.5
- EBGMEmpirical Bayes geometric mean
- O/E4.1
- a divided by E=12 divided by 2.9
- E = (a + b)(a + c) ÷ N. EBGM pulls this towards 1, with a prior fitted on the whole database.
Sample counts from Northbridge Pharma’s safety database. Thresholds are examples; χ² is Yates-corrected. Exampril and Northbridge Pharma are fictional.
Your data, and the public databases
Detection runs on your own safety database and on three public ones.
| Source | Kept by | Holds |
|---|---|---|
| Your safety database | You | Your own ICSRs |
| FAERSFDA Adverse Event Reporting System | US Food and Drug Administration | Adverse event and medication error reports for drugs and therapeutic biologics |
| EVDASEudraVigilance Data Analysis System | European Medicines Agency | Reports of suspected adverse reactions held in EudraVigilance, for medicines authorised in the EEA |
| VAERSVaccine Adverse Event Reporting System | US CDC and FDA | Reports of adverse events after vaccination |
Some events need only one report
Rules flag designated medical events, SUSARs, events of interest and your own criteria, without waiting for a ratio.
- Designated medical events
- Rare, serious events that justify review even from a single report. The EMA publishes the list.
- SUSARs
- Suspected unexpected serious adverse reactions reported from your clinical trials.
- Events of interest
- The events you have chosen to watch for each product.
- Your own rules
- Criteria you define, by product, by event or both.
Each match opens for review with its cases, in an ICSR view and a timeline view.
From detection to a recorded decision
The sample signal, step by step: who did each step and what was recorded. The steps are those of GVP Module IX, less signal confirmation, which the regulators carry out.
| Step | By | Recorded |
|---|---|---|
| Signal detection | Detection run | PRR 4.1 for Exampril and anaphylactic reaction, above the threshold |
| Signal validation | Signal analyst | The 12 reports reviewed against the source data; signal validated |
| Analysis and prioritisation | Safety physician | Serious event: high priority |
| Signal assessment | Safety physician | Case series and published literature assessed |
| Recommendation for action | Safety review committee | Update the reference safety information. Decision recorded and signed |
Sample signal. Exampril is fictional.
Audit trailEvery field change is versioned and attributable, with e-signature where required.
ValidationBuilt for 21 CFR Part 11 and EU Annex 11. IQ/OQ/PQ validation is part of every engagement.
Also in OnePV
- Case intake
Email, web forms, call centre (MICC) and partner reports in one triage queue.
- Safety database
ICSR processing, MedDRA and WHODrug coding, narratives, quality and medical review.
- Literature management
PubMed and Embase articles are screened, and relevant ones become cases inside the safety workflow.
- PV agreements (SDEA)
The safety data exchange agreements your partners report under.
One system for patients, medical devices, cosmetics and veterinary medicines.
Bring a pair you are watching
Anonymised or made up. We will take it from detection to a recorded decision with you.